These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
780 related articles for article (PubMed ID: 32391055)
1. Identification of Crucial Genes Associated With Immune Cell Infiltration in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis. Wang D; Liu J; Liu S; Li W Front Genet; 2020; 11():342. PubMed ID: 32391055 [TBL] [Abstract][Full Text] [Related]
2. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma. Li W; Lu J; Ma Z; Zhao J; Liu J Front Genet; 2019; 10():1323. PubMed ID: 32010188 [No Abstract] [Full Text] [Related]
3. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma. Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202 [TBL] [Abstract][Full Text] [Related]
4. Identification of the hub and prognostic genes in liver hepatocellular carcinoma Gao Q; Fan L; Chen Y; Cai J Front Mol Biosci; 2022; 9():1000847. PubMed ID: 36250027 [TBL] [Abstract][Full Text] [Related]
5. Identifying Dendritic Cell-Related Genes Through a Co-Expression Network to Construct a 12-Gene Risk-Scoring Model for Predicting Hepatocellular Carcinoma Prognosis. Huang C; Jiang X; Huang Y; Zhao L; Li P; Liu F Front Mol Biosci; 2021; 8():636991. PubMed ID: 34109210 [TBL] [Abstract][Full Text] [Related]
6. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633 [TBL] [Abstract][Full Text] [Related]
7. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis. Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R Front Genet; 2022; 13():907331. PubMed ID: 35938001 [No Abstract] [Full Text] [Related]
8. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma. Xu Q; Xu H; Chen S; Huang W Front Cell Dev Biol; 2021; 9():710207. PubMed ID: 34409040 [No Abstract] [Full Text] [Related]
9. Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis. Zhu W; Ru L; Ma Z Front Oncol; 2021; 11():626654. PubMed ID: 33777771 [TBL] [Abstract][Full Text] [Related]
10. Identification of a Four-Gene Signature With Prognostic Significance in Endometrial Cancer Using Weighted-Gene Correlation Network Analysis. Huang S; Pang L; Wei C Front Genet; 2021; 12():678780. PubMed ID: 34616422 [TBL] [Abstract][Full Text] [Related]
11. Identification, Verification and Pathway Enrichment Analysis of Prognosis-Related Immune Genes in Patients With Hepatocellular Carcinoma. Zhu Z; Song M; Li W; Li M; Chen S; Chen B Front Oncol; 2021; 11():695001. PubMed ID: 34616672 [TBL] [Abstract][Full Text] [Related]
12. Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis. Chi Q; Geng X; Xu K; Wang C; Zhao H Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32537629 [TBL] [Abstract][Full Text] [Related]
13. Construction of a ceRNA Network and a Prognostic lncRNA Signature associated with Vascular Invasion in Hepatocellular Carcinoma based on Weighted Gene Co-Expression Network Analysis. Tao H; Li J; Liu J; Yuan T; Zhang E; Liang H; Huang Z J Cancer; 2021; 12(13):3754-3768. PubMed ID: 34093785 [No Abstract] [Full Text] [Related]
14. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis. Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116 [TBL] [Abstract][Full Text] [Related]
15. Identification of Hub Genes and Their Correlation With Immune Infiltration Cells in Hepatocellular Carcinoma Based on GEO and TCGA Databases. Huang R; Liu J; Li H; Zheng L; Jin H; Zhang Y; Ma W; Su J; Wang M; Yang K Front Genet; 2021; 12():647353. PubMed ID: 33995482 [TBL] [Abstract][Full Text] [Related]
16. Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis. Mi N; Cao J; Zhang J; Fu W; Huang C; Gao L; Yue P; Bai B; Lin Y; Meng W; Li X Oncol Lett; 2020 Aug; 20(2):1695-1708. PubMed ID: 32724412 [TBL] [Abstract][Full Text] [Related]
17. Identifying novel biomarkers in hepatocellular carcinoma by weighted gene co-expression network analysis. Li B; Pu K; Wu X J Cell Biochem; 2019 Jul; 120(7):11418-11431. PubMed ID: 30746803 [TBL] [Abstract][Full Text] [Related]
18. Identification of hub genes in peripheral blood mononuclear cells for the diagnosis of hepatocellular carcinoma using a weighted gene co-expression network analysis. Ye Z; Zeng Z; Shen Y; Chen Z Exp Ther Med; 2020 Aug; 20(2):890-900. PubMed ID: 32742331 [TBL] [Abstract][Full Text] [Related]
19. Development and validation of a 14-gene signature for prognosis prediction in hepatocellular carcinoma. Zhang BH; Yang J; Jiang L; Lyu T; Kong LX; Tan YF; Li B; Zhu YF; Xi AY; Xu X; Yan LN; Yang JY Genomics; 2020 Jul; 112(4):2763-2771. PubMed ID: 32198063 [TBL] [Abstract][Full Text] [Related]
20. Weighted gene co-expression network analysis reveals prognostic and diagnostic significance of Feng T; Lai C; Zhong D; Luo L; Zou H; Wang G; Yang Q; Yao Y; Huang X J Gastrointest Oncol; 2022 Apr; 13(2):768-779. PubMed ID: 35557577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]